Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020

SELL
$10.89 - $21.47 $2,036 - $4,014
-187 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$10.23 - $24.56 $1,667 - $4,003
163 Added 679.17%
187 $2,000
Q4 2018

Feb 07, 2019

SELL
$22.03 - $32.01 $2,445 - $3,553
-111 Reduced 82.22%
24 $1,000
Q3 2018

Nov 02, 2018

BUY
$30.0 - $40.85 $3,330 - $4,534
111 Added 462.5%
135 $4,000
Q2 2018

Jul 31, 2018

BUY
$26.4 - $42.0 $633 - $1,008
24 New
24 $1,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $211M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.